Details

NameSymbolSector
EPIGRAL LIMITEDEPIGRALSpecialty Chemicals
Open
1230
High
1236.95
Low
1204.85
Close
1218.95
Volume
46501
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

5.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Epigral is  
None
Estimated Stoploss of Epigral is ₹  
1236.95
Epigral has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Epigral is  
Unpredictableℹ
. 

Trend

Epigral is in  
Uptrendℹ
. 
Price of Epigral is  
Upℹ
 by  

22.32

%. 
Target
Buy @ 

834.1

Sell @ 

1223.3

Current @ 

1218.95

Volume

The trade volumes of Epigral have become  
Deficientℹ
Though the volume trend for Epigral appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Epigral is  

Down

 by  

46.61

% 

Valuation

The current market price of Epigral is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3152cr and total assets worth ₹ 3152cr, the balance sheet of Epigral is:  
Balancedℹ
. 
Cashflow
Epigral has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 15cr

. It is  
Upℹ
 by  

236.36

%. 

(*Mar 2025)

50.93% i.e. ₹ 440cr earned in operatingℹ
30.21% i.e. ₹ 261cr spent in investingℹ
18.87% i.e. ₹ 163cr spent in financingℹ
0% in otherℹ
Epigral has  
Badℹ
 cash flow because there is  

Shortage

 of  

₹ 11cr

. It is  
Downℹ
 by  

10

%. 

(*Mar 2024)

49.32% i.e. ₹ 397cr earned in operatingℹ
49.81% i.e. ₹ 401cr spent in investingℹ
0.87% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Income
The income of Epigral is  

₹ 589cr

 and  

Profit

 is :  

₹ 51cr

(*Sep 2025)

Epigral Profit is up by:  

86.05

% and Income is Down by:  

2.69

% 

(*Sep 2025)

The income of Epigral is  

₹ 614cr

 and  

Profit

 is :  

₹ 160cr

(*Jun 2025)

Epigral Profit is down by:  

16.5

% and Income is Down by:  

2.77

% 

(*Jun 2025)

The income of Epigral is  

₹ 631cr

 and  

Profit

 is :  

₹ 86cr

(*Mar 2025)

Epigral Profit is up by:  

28.75

% and Income is Up by:  

2.85

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.